DURAFLO II HEPARIN TREATED FEMORAL CANNULAE MODELS— 510(k) K905312
Substantially EquivalentBaxter Bentley Laboratories, Inc.
FDA 510(k) clearance K905312 for DURAFLO II HEPARIN TREATED FEMORAL CANNULAE MODELS, Substantially Equivalent on 1991-01-15. Applicant: Baxter Bentley Laboratories, Inc..
Clearance details
- Applicant
- Baxter Bentley Laboratories, Inc.
- Product code
- Code DWF
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Irvine, CA, US
Adverse events under product code DWF
product code DWF- Death
- 106
- Injury
- 386
- Malfunction
- 2,323
- Total
- 2,815
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.